Abstract
We report two cases with small cell lung cancer (SCLC) receiving multicyclic dose-intensified chemotherapy (DI-CT) supported by autologous blood progenitor cell transplantation (ABPCT). Both cases were initially treated with cisplatin (CDDP), etoposide (ETP) and concurrent thoracic irradiation, however they had recurrent disease within a year. After receiving conventional chemotherapy, they underwent multicyclic DI-CT consisting of CDDP, ETP and ifosfamide supported by G-CSF and ABPCT. Definite regression of the tumors was observed. Severe neutropenia and thrombocytopenia were encountered but they were reversible and no life-threatening complications were experienced. These results suggest the feasibility and effectiveness of multicyclic DI-CT and the usefulness of ABPCT as a treatment option for relapsed SCLC.
Original language | English |
---|---|
Pages (from-to) | 4229-4232 |
Number of pages | 4 |
Journal | Anticancer research |
Volume | 23 |
Issue number | 5 B |
Publication status | Published - Sept 1 2003 |
Keywords
- Autologous blood progenitor cell transplantation (ABPCT)
- Dose-intensive chemotherapy
- Second-line chemotherapy
- Small cell lung cancer
ASJC Scopus subject areas
- Oncology
- Cancer Research